Pro Medicus Ltd. said on Wednesday its half-year profit for the six months ended December 31, 2025, reached a record high, prompting a 12.4% surge in its shares. The Australian developer of medical imaging software reported financial results that exceeded market expectations, though the company did not disclose specific profit figures in its preliminary update.
The company attributed the record performance to strong demand for its cloud-based imaging solutions, particularly in North America and Europe. Pro Medicus’ software is widely used in radiology departments, enabling remote diagnostics and workflow optimization for healthcare providers.
Shares of Pro Medicus closed 12.4% higher at A$65.00 (US$42.50) on the Australian Securities Exchange, extending gains after the earnings update. The stock has risen nearly 40% over the past three months, outperforming broader market benchmarks in the healthcare technology sector.
Analysts noted that Pro Medicus’ growth reflects broader trends in the healthcare IT sector, where cloud-based solutions are gaining traction due to their scalability and cost efficiency. The company has maintained a consistent track record of profitability and revenue growth since its initial public offering in 2016.
Pro Medicus did not provide a formal earnings call transcript or detailed financial breakdown in its announcement. Further updates are expected when the company releases its full half-year financial results in late February 2026.
